Managed Healthcare Executive ® Board Member John D. Halamka, MD, MS, has recently taken the title as president of the Mayo Clinic Platform.
Managed Healthcare Executive ® Board Member John D. Halamka, MD, MS, has recently taken the title as president of the Mayo Clinic Platform.
Halamka will join the Mayo Clinic team January 1, 2020.
The Mayo Clinic Platform leads a portfolio of new digital platform businesses focused on transforming health by leveraging artificial intelligence, the internet of things, and an ecosystem of partners for Mayo Clinic.
Previously, Halamka was executive director of the Health Technology Exploration Center for Beth Israel Lahey Health in Massachusetts and served as chief information officer at Beth Israel Deaconess Medical Center for more than 20 years.
"The Mayo Platform position offers an opportunity to improve quality, safety, and access to care worldwide using a combination of technology, policy, process and people,” Halamka says. “I chose to move to Mayo because I think it will be very impactful. Over the next five years, although healthcare will remain an empathetic care business, it will increasingly become a data business and senior executives must prepare for a digital health future."
Related: Mayo Clinic, Google to Form Healthcare Partnership
Halamka currently serves as chairman of New England Healthcare Exchange Network Inc. and as a practicing emergency medicine physician.
Additionally, Halamka was the International Healthcare Innovation Professor at Harvard Medical School.
As the leader for innovation at the $7 billion Beth Israel Lahey Health, he oversaw digital health relationships with industry, academia, and government worldwide. As a Harvard Medical School professor, he served the George W. Bush administration, the Obama administration and governments around the world planning their healthcare information (IT) strategies.
In his role at Beth Israel Deaconess Medical Center, Halamka was responsible for all clinical, financial, administrative and academic IT.
Aside from his position at the medical center, he has written a dozen books about technology-related issues, hundreds of articles, and thousands of posts on the Geek Doctor blog.
Halamka completed his undergraduate studies at Stanford University, where he received degrees in medical microbiology and in public policy with a focus on technology issues. He received his medical degree at the University of California, San Francisco, and simultaneously pursued graduate work in bioengineering at the University of California, Berkeley, focusing on technology issues in medicine.
Halamka completed his residency at Harbor-UCLA Medical Center in the Department of Emergency Medicine.
He runs Unity Farm in Sherborn, Massachusetts, and is the caretaker for 250 animals, 30 acres of agricultural production, and a cidery and winery.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Dupixent Is Linked to a Higher Risk of Psoriasis in Patients With Atopic Dermatitis
July 8th 2025AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and psoriasis driven by Th17 inflammation. However, newer research has shown that these diseases can overlap in patients and may even share common pathways.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Autoimmune Diseases Almost Double Mental Health Disorder Risk
July 7th 2025The prevalence of autoimmune disease patients with a mental health disorder is almost twice the number of patients without, suggesting there is a link between inflammation and conditions such as depression, anxiety disorder and bipolar disorder.
Read More